SXI Form 4: Director Granted 149 Phantom Stock Units Under 2018 Plan
Rhea-AI Filing Summary
Robin J. Davenport, a director of Standex International Corporation (SXI), acquired 149 phantom stock units on 08/23/2025 under the Management Stock Purchase component of the companys 2018 Omnibus Incentive Plan. These units are a contingent purchase that will vest and be settled in the form of 149 shares of common stock on 08/23/2028. The reported transaction shows a conversion price of $0, and the ownership is reported as direct with 149 shares beneficially owned following the transaction. The filing indicates this award vests three years after purchase and is intended to convert to common stock at vesting.
Positive
- Director alignment: Award vests into common stock, aligning the directors interests with shareholders over three years
- Clear terms: Vesting date and settlement in common stock are explicitly disclosed (149 shares vesting 08/23/2028)
Negative
- None.
Insights
TL;DR: Director received a standard time‑based equity award that aligns interests with shareholders but is not material to ownership.
The reported acquisition of 149 phantom stock units under the 2018 Omnibus Incentive Plan is a routine, time‑vested compensation event for a director. The award vests three years after purchase and converts to common stock, which supports alignment of the directors incentives with long‑term shareholder value. The size—149 shares—is small relative to typical public company capitalization and unlikely to materially affect control or share count. No cash consideration is reported, consistent with contingent phantom stock awards.
TL;DR: This is a standard management plan contingent purchase that rewards retention; it appears administratively routine and non‑dilutive now.
The transaction is recorded as a contingent purchase of phantom stock units that will convert into 149 common shares at vesting on 08/23/2028. Such awards are common for retention and director alignment. The $0 price and the phantom-unit structure indicate no immediate dilution until settlement and no cash outlay by the company. The disclosure provides clear vesting and settlement terms but does not indicate acceleration provisions or potential aggregate ownership beyond the 149 shares disclosed.